Unmethylated MLH1 has a sensitivity of 94% and a specificity of 88% for the identification of MLH1 mutation carriers in patients with a MSI/dMMR CRC with a loss of MLH1 [241]. This evidence concerns the gene MLH1 and colorectal carcinoma.